Coronavirus disease 2019 vaccine in pediatric post-kidney transplantation
Description
CONCLUSION: The vaccine had a favorable safety profile in 12- to 15-year-old kidney transplant recipients, producing a greater measured antibody response than that in older transplant recipients.
